|Podcasts|December 23, 2021
Upcoming Podcast on ADHD Treatment Options
Author(s)Stephen V. Faraone, MD, PhD, Chris Aiken, MD
Advertisement
Stimulant medications have long been the mainstay of treatment for attention-deficit/hyperactivity disorder, but psychopharmacology is no longer the only game in town. Join us for a discussion on new nonpharmacological treatment approaches as Dr Chris Aiken, Psychiatric TimesTM Mood Disorders Section Editor and the Director of the Mood Treatment Center, talks with Dr Stephen Faraone, Distinguished Professor and Vice Chair of Research of Psychiatry and Behavioral Sciences at Upstate Medical University.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves ProlivRX: First Prescription, Physician-Directed, At-Home Brain Neuromodulation Therapy for MDD
2
What Makes It So Special? A Review of the Mechanisms of Action of Lamotrigine, Carbamazepine, and Valproic Acid and How They Differ From Other Antiepileptics
3
Anticholinergic Burden and Its Effect on Cognition in Psychosis
4
Progress Report: Second Interim Safety Review of Phase 3 Trial of LPCN 1154 in Postpartum Depression
5













